Sign Out
Palliative treatment of locally advanced, non-metastatic hormone-dependent prostate cancer, as an alternative to surgical castration
Treatment of metastatic hormone-dependent prostate cancer.
As adjuvant treatment to radiotherapy in patients with high-risk localized or locally advanced prostate cancer.
Additional Indication for Triptorelin 3.75 mg Lyophilized Powder for Injection (IM): As adjuvant treatment, in combination with tamoxifen or an aromatase inhibitor, of hormone receptor positive early stage breast cancer in women at high risk of recurrence who are confirmed as premenopausal after completion of chemotherapy.
For the pituitary down-regulation in the context of assisted reproduction technology.
Additional Indication for Triptorelin 3.75 mg Lyophilized Powder for Injection (IM/SC) and 11.25 mg Lyophilized Powder for Injection (IM): Treatment of endometriosis.
Additional Indication for Triptorelin 22.5 mg Lyophilized Powder for Injection (IM): Treatment of central precocious puberty (CPP) in children 2 years and older with an onset of CPP before 8 years in girls and 10 years in boys.
